This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, H. Articles by Dahlman-Wright, K. Search for Related Content PubMed PubMed Citation Articles by Gao, H. Articles by Dahlman-Wright, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL

Genome-Wide Identification of Estrogen Receptor -Binding Sites in Mouse Liver

Department of Biosciences and Nutrition (H.G., S.F., J.-A.G., K.D.-W.), Karolinska Institutet, Novum, S141 57 Huddinge, Sweden; and The Bioinformatics Centre (A.S.), Department of Molecular Biology & Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 København N, Denmark

Address all correspondence and requests for reprints to: Hui Gao, Department of Biosciences and Nutrition, Karolinska Institutet, Novum, S-14157 Huddinge, Sweden. E-mail: hui.gao{at}biosci.ki.se.

We report the genome-wide identification of estrogen receptor (ER)-binding regions in mouse liver using a combination of chromatin immunoprecipitation and tiled microarrays that cover all nonrepetitive sequences in the mouse genome. This analysis identified 5568 ER-binding regions. In agreement with what has previously been reported for human cell lines, many ER-binding regions are located far away from transcription start sites; approximately 40% of ER-binding regions are located within 10 kb of annotated transcription start sites. Almost 50% of ER-binding regions overlap genes. The majority of ER-binding regions lie in regions that are evolutionarily conserved between human and mouse. Motif-finding algorithms identified the estrogen response element, and variants thereof, together with binding sites for activator protein 1, basic-helix-loop-helix proteins, ETS proteins, and Forkhead proteins as the most common motifs present in identified ER-binding regions. To correlate ER binding to the promoter of specific genes, with changes in expression levels of the corresponding mRNAs, expression levels of selected mRNAs were assayed in livers 2, 4, and 6 h after treatment with ER-selective agonist propyl pyrazole triol. Five of these eight selected genes, Shp, Stat3, Pdgds, Pck1, and Pdk4, all responded to propyl pyrazole triol after 4 h treatment. These results extend our previous studies using gene expression profiling to characterize estrogen signaling in mouse liver, by characterizing the first step in this signaling cascade, the binding of ER to DNA in intact chromatin.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα

Ligands:   17β-Estradiol

This article has been cited by other articles:

				R. Singhal, K. Shankar, T. M Badger, and M. J Ronis Hepatic gene expression following consumption of soy protein isolate in female Sprague-Dawley rats differs from that produced by 17{beta}-estradiol treatment J. Endocrinol., July 1, 2009; 202(1): 141 - 152. [Abstract] [Full Text] [PDF]

				J. Eeckhoute, M. Lupien, C. A. Meyer, M. P. Verzi, R. A. Shivdasani, X. S. Liu, and M. Brown Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers Genome Res., March 1, 2009; 19(3): 372 - 380. [Abstract] [Full Text] [PDF]

				S. Safe and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol., November 1, 2008; 41(5): 263 - 275. [Abstract] [Full Text] [PDF]

				L Lundholm, G Bryzgalova, H Gao, N Portwood, S Falt, K D Berndt, A Dicker, D Galuska, J R Zierath, J-A Gustafsson, et al. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms J. Endocrinol., November 1, 2008; 199(2): 275 - 286. [Abstract] [Full Text] [PDF]

				R. Nielsen, T. A. Pedersen, D. Hagenbeek, P. Moulos, R. Siersbaek, E. Megens, S. Denissov, M. Borgesen, K.-J. Francoijs, S. Mandrup, et al. Genome-wide profiling of PPAR{gamma}:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis Genes & Dev., November 1, 2008; 22(21): 2953 - 2967. [Abstract] [Full Text] [PDF]

				G. Deblois and V. Giguere Nuclear Receptor Location Analyses in Mammalian Genomes: From Gene Regulation to Regulatory Networks Mol. Endocrinol., September 1, 2008; 22(9): 1999 - 2011. [Abstract] [Full Text] [PDF]

				E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing Nucleic Acids Res., August 1, 2008; 36(14): 4549 - 4564. [Abstract] [Full Text] [PDF]